BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

374 related articles for article (PubMed ID: 641141)

  • 1. The key role of peptidoglycan in the opsonization of Staphylococcus aureus.
    Peterson PK; Wilkinson BJ; Kim Y; Schmeling D; Douglas SD; Quie PG; Verhoef J
    J Clin Invest; 1978 Mar; 61(3):597-609. PubMed ID: 641141
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of Staphylococcus aureus cell-wall peptidoglycan, teichoic acid and protein A in the processes of complement activation and opsonization.
    Verbrugh HA; Van Dijk WC; Peters R; Van Der Tol ME; Verhoef J
    Immunology; 1979 Jul; 37(3):615-21. PubMed ID: 500119
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Staphylococcus aureus opsonization mediated via the classical and alternative complement pathways. A kinetic study using MgEGTA chelated serum and human sera deficient in IgG and complement factors C1s and C2.
    Verbrugh HA; Van Dijk WC; Peters R; Van Der Tol ME; Peterson PK; Verhoef J
    Immunology; 1979 Mar; 36(3):391-7. PubMed ID: 108204
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Opsonization of encapsulated Staphylococcus aureus: the role of specific antibody and complement.
    Verbrugh HA; Peterson PK; Nguyen BY; Sisson SP; Kim Y
    J Immunol; 1982 Oct; 129(4):1681-7. PubMed ID: 7108223
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Opsonic requirements for staphylococcal phagocytosis. Heterogeneity among strains.
    Verhoef J; Peterson P; Kim Y; Sabath LD; Quie PG
    Immunology; 1977 Aug; 33(2):191-7. PubMed ID: 415969
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Opsonic recognition of staphylococci mediated by cell wall peptidoglycan: antibody-independent activation of human complement and opsonic activity of peptidoglycan antibodies.
    Verbrugh HA; van Dijk WC; Peters R; van Erne ME; Daha MR; Peterson PK; Verhoef J
    J Immunol; 1980 Mar; 124(3):1167-73. PubMed ID: 7358981
    [No Abstract]   [Full Text] [Related]  

  • 7. Suppression of phagocytosis and chemotaxis by cell wall components of Staphylococcus aureus.
    Musher DM; Verbrugh HA; Verhoef J
    J Immunol; 1981 Jul; 127(1):84-8. PubMed ID: 7240751
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Location of peptidoglycan and teichoic acid on the cell wall surface of Staphylococcus aureus as determined by immunoelectron microscopy.
    Umeda A; Yokoyama S; Arizono T; Amako K
    J Electron Microsc (Tokyo); 1992 Feb; 41(1):46-52. PubMed ID: 1619377
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Complement-mediated phagocytosis of Pseudomonas aeruginosa.
    Peterson PK; Kim Y; Schmeling D; Lindemann M; Verhoef J; Quie PG
    J Lab Clin Med; 1978 Dec; 92(6):883-94. PubMed ID: 105067
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cryptic peptidoglycan and the antiphagocytic effect of the Staphylococcus aureus capsule: model for the antiphagocytic effect of bacterial cell surface polymers.
    Wilkinson BJ; Peterson PK; Quie PG
    Infect Immun; 1979 Feb; 23(2):502-8. PubMed ID: 422250
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Specific serum Ig recognizing staphylococcal wall teichoic acid induces complement-mediated opsonophagocytosis against Staphylococcus aureus.
    Jung DJ; An JH; Kurokawa K; Jung YC; Kim MJ; Aoyagi Y; Matsushita M; Takahashi S; Lee HS; Takahashi K; Lee BL
    J Immunol; 2012 Nov; 189(10):4951-9. PubMed ID: 23071283
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of encapsulation on staphylococcal opsonization and phagocytosis by human polymorphonuclear leukocytes.
    Peterson PK; Wilkinson BJ; Kim Y; Schmeling D; Quie PG
    Infect Immun; 1978 Mar; 19(3):943-9. PubMed ID: 640738
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activation of complement by cell surface components of Staphylococcus aureus.
    Wilkinson BJ; Kim Y; Peterson PK; Quie PG; Michael AF
    Infect Immun; 1978 May; 20(2):388-92. PubMed ID: 669803
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recognition of Staphylococcus aureus by human phagocytes. Signals and disguises of the bacterial surface.
    Peterson PK; Quie PG; Kim Y; Wilkinson BJ; Verbrugh HA; Verhoef J
    Scand J Infect Dis Suppl; 1983; 41():67-78. PubMed ID: 6589763
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Cell wall of pigmentless variants of Staphylococcus aureus].
    Ignatov VV; Popov IuA; Nikitina VE; Kats LN
    Mikrobiologiia; 1976 JUL-AUG; 45(4):668-72. PubMed ID: 979686
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stimulation of reticuloendothelial system and toxicity to macrophages of Staphylococcus aureus cell wall, peptidoglycan, and teichoic acid.
    Dziarski R
    Zentralbl Bakteriol Orig A; 1977 Jul; 238(3):320-9. PubMed ID: 910577
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dichotomy between opsonization and serum complement activation by encapsulated staphylococci.
    Peterson PK; Kim Y; Wilkinson BJ; Schmeling D; Michael AF; Quie PG
    Infect Immun; 1978 Jun; 20(3):770-5. PubMed ID: 352958
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The staphylococcal surface-glycopolymer wall teichoic acid (WTA) is crucial for complement activation and immunological defense against Staphylococcus aureus infection.
    Kurokawa K; Takahashi K; Lee BL
    Immunobiology; 2016 Oct; 221(10):1091-101. PubMed ID: 27424796
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cell-mediated immune reactions in vitro to cell walls and peptidoglycan from Staphylococcus aureus.
    Targowski SP; Berman DT
    Z Immunitatsforsch Exp Klin Immunol; 1975 Jul; 149(2-4):295-301. PubMed ID: 126563
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clindamycin enhances opsonization of Staphylococcus aureus.
    Milatovic D; Braveny I; Verhoef J
    Antimicrob Agents Chemother; 1983 Sep; 24(3):413-7. PubMed ID: 6638997
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.